FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine | Frequently asked questions about COVID-19 vaccination |
---|---|
Centers for Disease Control and Prevention | Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera |
Centers for Disease Control and Prevention.
15Vaccine Adverse Event Reporting System | Centers for Disease Control and Prevention |
---|---|
COVID-19 vaccines and allergic reactions | mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants |